Osteosarcoma cost-effectiveness of therapy
Jump to navigation
Jump to search
|
Osteosarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Osteosarcoma cost-effectiveness of therapy On the Web |
|
American Roentgen Ray Society Images of Osteosarcoma cost-effectiveness of therapy |
|
Risk calculators and risk factors for Osteosarcoma cost-effectiveness of therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammadmain Rezazadehsaatlou[2].
Overview
Treatment process consisted of the local control (surgical resection, amputation which usually requires around week 10 of therapy). Additionally, patients require frequent admission during their chemotherapy treatment phase.
Osteosarcoma cost-effectiveness of therapy
- Treatment process consisted of the local control (surgical resection, amputation which usually requires around week 10 of therapy).
- Additionally, patients require frequent admission during their chemotherapy treatment phase.[1][2]
References
- ↑ Luetke A, Meyers PA, Lewis I, Juergens H (May 2014). "Osteosarcoma treatment - where do we stand? A state of the art review". Cancer Treat. Rev. 40 (4): 523–32. doi:10.1016/j.ctrv.2013.11.006. PMID 24345772.
- ↑ Anderson ME (January 2016). "Update on Survival in Osteosarcoma". Orthop. Clin. North Am. 47 (1): 283–92. doi:10.1016/j.ocl.2015.08.022. PMID 26614941.